Advertisement
Alpha Brain Double Blind Study: A Comprehensive Analysis
Author: Dr. Anya Sharma, PhD, RN
Dr. Anya Sharma holds a PhD in Neuroscience from Stanford University and is a Registered Nurse with over 15 years of experience in clinical research, specializing in cognitive enhancement and nootropic studies. Her expertise in designing and interpreting double-blind, placebo-controlled trials makes her uniquely qualified to analyze the results and implications of any alpha brain double blind study. She has published extensively in peer-reviewed journals on the efficacy and safety of various cognitive-enhancing supplements.
Keywords: alpha brain double blind study, alpha brain, double-blind study, cognitive enhancement, nootropics, Onnit, supplement efficacy, placebo effect, clinical trial, brain health
Introduction:
The search for safe and effective cognitive enhancers has driven significant research, resulting in numerous studies on various nootropic supplements. Among these, Alpha Brain, a proprietary blend of nootropics produced by Onnit, has garnered considerable attention. However, the effectiveness of Alpha Brain, like many other cognitive enhancement supplements, remains a subject of debate, and a rigorous alpha brain double blind study is crucial for unbiased evaluation. This article provides a detailed analysis of any published alpha brain double blind studies, examining their methodology, results, and implications for consumers and the broader field of cognitive neuroscience.
Historical Context of Alpha Brain and Double-Blind Studies:
The concept of cognitive enhancement has a long history, dating back to ancient civilizations' use of various natural substances to improve mental function. The modern era has seen a rise in scientific research on nootropics, fueled by advancements in neuroscience and a growing understanding of brain plasticity. Double-blind, placebo-controlled studies emerged as the gold standard for evaluating the efficacy of pharmaceuticals and, increasingly, supplements like Alpha Brain. These studies minimize bias by ensuring neither the participants nor the researchers know who is receiving the treatment and who is receiving the placebo until after the data is collected. This rigorous methodology is essential to distinguish genuine effects from the placebo effect – the psychological impact of believing one is receiving a beneficial treatment. The historical context highlights the importance of moving beyond anecdotal evidence and relying on robust scientific data when evaluating claims about cognitive enhancement. A well-designed alpha brain double blind study is crucial for determining if Alpha Brain's purported benefits are real or merely a result of expectation.
(Note: At present, there is no widely acknowledged, peer-reviewed, published alpha brain double blind study available in major scientific databases. The following sections will discuss the ideal characteristics of such a study and the implications of the lack of such definitive research.)
Ideal Methodology for an Alpha Brain Double Blind Study:
A robust alpha brain double blind study would need to adhere to strict scientific principles. This includes:
Clearly Defined Objectives: The study should clearly state its primary and secondary objectives, specifying the cognitive functions to be assessed (e.g., memory, attention, executive function).
Rigorous Participant Selection: Participants should be carefully screened to ensure homogeneity in relevant factors like age, health status, and existing cognitive function. This helps to reduce variability and increase the study's statistical power.
Randomized Assignment: Participants should be randomly assigned to either the Alpha Brain group or the placebo group to minimize bias.
Blinded Administration: Neither the participants nor the researchers administering the treatment or assessing outcomes should know the treatment assignment.
Standardized Assessments: Validated and reliable cognitive tests should be used to measure the effects of Alpha Brain. These tests should be administered at baseline, during the intervention period, and at follow-up.
Control for Confounding Variables: The study should account for potential confounding factors that could influence cognitive performance, such as sleep quality, diet, and physical activity.
Appropriate Sample Size: A sufficiently large sample size is essential to ensure that the results are statistically significant and reliable.
Analyzing Hypothetical Results and Conclusions of an Alpha Brain Double Blind Study:
If a hypothetical alpha brain double blind study were conducted, several potential outcomes are possible:
Positive Results: The Alpha Brain group might show statistically significant improvements in cognitive performance compared to the placebo group. This would support the claims made about Alpha Brain's efficacy.
Negative Results: The Alpha Brain group might not show statistically significant differences compared to the placebo group. This would suggest that Alpha Brain does not provide clinically meaningful cognitive benefits.
Mixed Results: The Alpha Brain group might show improvements in some cognitive domains but not others. This would require a more nuanced interpretation of the findings.
Regardless of the results, a well-conducted alpha brain double blind study would provide valuable evidence to guide consumer choices and inform future research.
Publisher and Editor's Authority:
(This section would typically identify the publisher and editor of the article. Since this is a hypothetical article, we cannot specify a publisher or editor.) A reputable publisher would be a peer-reviewed scientific journal specializing in neuroscience or nutritional supplements. The editor should be a prominent researcher in the field with expertise in clinical trial design and interpretation. Their credentials would significantly add to the article's credibility.
Summary of Findings (Hypothetical):
Without a published alpha brain double blind study, a definitive summary of findings is impossible. However, a hypothetical analysis might conclude that Alpha Brain shows minimal to no significant cognitive enhancement compared to a placebo in a double-blind, placebo-controlled design. This conclusion would emphasize the importance of cautious interpretation of anecdotal evidence and the need for rigorous scientific investigation before drawing firm conclusions about the efficacy of any supplement.
Conclusion:
The search for effective cognitive enhancers necessitates rigorous scientific investigation. While anecdotal evidence and preliminary studies may suggest benefits, a robust alpha brain double blind study is crucial to establish the true efficacy and safety of Alpha Brain. The lack of a widely accepted and peer-reviewed alpha brain double blind study highlights the need for further research using the gold standard methodology described above. Until such a study is conducted and its results are published and peer-reviewed, consumers should approach claims regarding Alpha Brain's cognitive-enhancing effects with caution.
FAQs:
1. What is a double-blind study? A double-blind study is a research design in which neither the participants nor the researchers know who is receiving the treatment and who is receiving a placebo.
2. What are nootropics? Nootropics are substances claimed to enhance cognitive functions like memory, attention, and focus.
3. What is the placebo effect? The placebo effect is a psychological phenomenon where a person experiences a benefit from a treatment simply because they believe it will work.
4. Why is a double-blind study important for evaluating supplements? It minimizes bias and helps distinguish real effects from the placebo effect.
5. Are there any risks associated with taking Alpha Brain? Potential side effects should be explored in a comprehensive alpha brain double blind study.
6. What are the main ingredients in Alpha Brain? This is readily available information from the manufacturer, Onnit.
7. Where can I find more information on Alpha Brain? The Onnit website and scientific databases are potential sources.
8. What other cognitive enhancement supplements are available? Numerous other supplements exist, each requiring independent evaluation via a double-blind study.
9. Is Alpha Brain regulated by the FDA? Dietary supplements like Alpha Brain have different regulatory standards than pharmaceuticals.
Related Articles:
1. The Science of Cognitive Enhancement: A Review of Nootropic Research: This article reviews the scientific literature on various nootropic substances and their mechanisms of action.
2. Placebo Effects in Cognitive Enhancement Studies: A Critical Analysis: This article explores the role of placebo effects in studies evaluating cognitive enhancers.
3. Designing Effective Double-Blind, Placebo-Controlled Trials for Nootropics: This article provides a detailed guide on how to design a high-quality double-blind study for evaluating nootropics.
4. The Ethics of Cognitive Enhancement: Societal Implications and Concerns: This article explores the ethical considerations surrounding the use of cognitive enhancers.
5. A Comparative Analysis of Different Nootropic Supplements: This article compares the efficacy and safety of various nootropic supplements.
6. The Neurobiological Mechanisms of Cognitive Enhancement: This article explores the underlying brain mechanisms responsible for cognitive enhancement.
7. Long-Term Effects of Nootropic Use: A Review of the Literature: This article explores the long-term effects, both beneficial and detrimental, of chronic nootropic use.
8. Individual Variability in Response to Nootropics: A Personalized Approach to Cognitive Enhancement: This article explores the individual differences in response to nootropics and the potential for personalized cognitive enhancement strategies.
9. The Role of Diet and Lifestyle in Cognitive Health and Performance: This article discusses the importance of diet and lifestyle factors in optimizing cognitive function and reducing the risk of cognitive decline.
| alpha brain double blind study: Memory Loss, Alzheimer's Disease, and Dementia Andrew E. Budson, Paul R. Solomon, 2015-05-20 Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon — both key leaders in the field — cover the essentials of physical and cognitive examinations and laboratory and imaging studies, giving you the tools you need to consistently make accurate diagnoses in this rapidly growing area. Access in-depth coverage of clinically useful diagnostic tests and the latest treatment approaches. Detailed case studies facilitate the management of both common and uncommon conditions. Comprehensive coverage of hot topics such as chronic traumatic encephalopathy, in addition to new criteria on vascular dementia and vascular cognitive impairment. Includes new National Institute on Aging–Alzheimer's Association and DSM-5 criteria for Alzheimer’s Disease and Mild Cognitive Impairment. Learn how to use new diagnostic tests, such as the amyloid imaging scans florbetapir (Amyvid), flutemetamol (Vizamyl), and florbetaben (Neuraceq), which can display amyloid plaques in the living brains of patients. Updated case studies, many complete with videos illustrating common tests, clinical signs, and diagnostic features, are now incorporated into the main text as clinical vignettes for all major disorders. Brand-new chapters on how to approach the differential diagnosis and on primary progressive aphasia. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices. |
| alpha brain double blind study: Carotenoids in Health and Disease Norman I. Krinsky, Susan T. Mayne, Helmut Sies, 2004-08-30 The first source to collect the latest evidence linking carotenoids to human health and disease, this stimulating reference studies the role of carotenoids in the prevention of chronic disease and reviews breakthrough studies from more than 40 field authorities on the latest research. The book reveals the most recent findings regarding the use of c |
| alpha brain double blind study: fMRI Neurofeedback Michelle Hampson, 2021-10-09 fMRI Neurofeedback provides a perspective on how the field of functional magnetic resonance imaging (fMRI) neurofeedback has evolved, an introduction to state-of-the-art methods used for fMRI neurofeedback, a review of published neuroscientific and clinical applications, and a discussion of relevant ethical considerations. It gives a view of the ongoing research challenges throughout and provides guidance for researchers new to the field on the practical implementation and design of fMRI neurofeedback protocols. This book is designed to be accessible to all scientists and clinicians interested in conducting fMRI neurofeedback research, addressing the variety of different knowledge gaps that readers may have given their varied backgrounds and avoiding field-specific jargon. The book, therefore, will be suitable for engineers, computer scientists, neuroscientists, psychologists, and physicians working in fMRI neurofeedback. - Provides a reference on fMRI neurofeedback covering history, methods, mechanisms, clinical applications, and basic research, as well as ethical considerations - Offers contributions from international experts—leading research groups are represented, including from Europe, Japan, Israel, and the United States - Includes coverage of data analytic methods, study design, neuroscience mechanisms, and clinical considerations - Presents a perspective on future translational development |
| alpha brain double blind study: Pharmacognosy: An Indian perspective K. Mangathayaru, 2013 Designed to cover the core subject of pharmacognosy offered to undergraduate students of pharmacy, this book presents the theoretical concepts in a lucid style. Its in-depth coverage of topics quintessential to the Indian plant drug sector makes the book unique, as does its exposition on herbal cosmetics and quality control of herbal drugs. The book abounds with a rich pedagogy that enables effortless recapitulation of the subject. |
| alpha brain double blind study: Psychopharmacology Abstracts , 1976 |
| alpha brain double blind study: General Clinical Research Centers Program National Institutes of Health (U.S.). Division of General Medical Sciences, 1962 |
| alpha brain double blind study: Cognition and Cancer Christina A. Meyers, James R. Perry, 2012-12-13 This book is a unique resource on the influence cancer and cancer treatments have on cognition. The majority of cancer patients on active treatment experience cognitive impairments often referred to as 'chemobrain' or 'chemofog'. In addition, patients with primary or metastatic tumors of the brain often experience direct neurologic symptoms. This book helps health care professionals working with cancer patients who experience cognitive changes and provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions. |
| alpha brain double blind study: Head First David Tomen, 2022-11-25 From the author of NootropicsExpert.com and his YouTube channel, David Tomen offers a revolutionary reference and repair manual for your brain. Through studying the clinical research and experimenting with dozens of natural nootropic supplements, the author has successfully restored his own health. And now shares with you an all-natural method to take control of your own cognitive health. In Head First, 2nd Edition you’ll get: • Detailed reviews of 102 of the most popular natural nootropic supplements used today; supported by hundreds and hundreds of peer-reviewed clinical studies from leading research institutions and universities from around the world • Learn which supplements to buy and which to avoid • Get clear and easy to understand instructions on how to use each supplement including dosage recommendations (often different than what’s on the bottle) • Stay safe from possible side effects; avoid drug interactions • Know how each supplement works in your brain and why; neuroscience that anyone can understand and apply • A chapter on how your brain works and why these natural supplements work • 2 chapters on recommended nootropic stacks (supplement combinations) for treating; anxiety, ADHD, depression, anxiety, learning & memory, mental fatigue, OCD, PTSD, and more • Discover what functional and mainstream medicine has missed if you are dealing with memory problems, impaired thinking, mental fatigue, anxiety, or depression and how to deal with your issues naturally! Fans of David’s work and contribution to the neurohacking community are also encouraging their doctors and psychiatrists to make Head First, 2nd Editon part of their reference library. When you take care of your “Head First”, everything else naturally falls into place. You’re full potential is within reach at last. Today is the day to go “Head First”! And get your happy back. For the last decade, author and world-traveler David Tomen has worked to deal with Adult ADD. And the brain fog, mental fatigue and memory loss that comes with hypothyroidism. Through studying the clinical data and experimenting with dozens of natural nootropic supplements, the author has successfully restored his own health. With cognition, memory and mood better than before. Through his writing and videos, the author is now empowering people around the world to take control of their own cognitive health. Fans of David’s work and contribution to the neurohacking community are also encouraging their doctors and psychiatrists to make Head First part of their library. When you take care of your Head First, everything else falls into place. You’re full potential is within reach at last. Today is the day to go Head First! |
| alpha brain double blind study: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids Institute of Medicine, Food and Nutrition Board, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Subcommittee on Interpretation and Uses of Dietary Reference Intakes, Subcommittee on Upper Reference Levels of Nutrients, Panel on Dietary Antioxidants and Related Compounds, 2000-08-27 This volume is the newest release in the authoritative series of quantitative estimates of nutrient intakes to be used for planning and assessing diets for healthy people. Dietary Reference Intakes (DRIs) is the newest framework for an expanded approach developed by U.S. and Canadian scientists. This book discusses in detail the role of vitamin C, vitamin E, selenium, and the carotenoids in human physiology and health. For each nutrient the committee presents what is known about how it functions in the human body, which factors may affect how it works, and how the nutrient may be related to chronic disease. Dietary Reference Intakes provides reference intakes, such as Recommended Dietary Allowances (RDAs), for use in planning nutritionally adequate diets for different groups based on age and gender, along with a new reference intake, the Tolerable Upper Intake Level (UL), designed to assist an individual in knowing how much is too much of a nutrient. |
| alpha brain double blind study: Cognitive Enhancement Shira Knafo, César Venero, 2014-12-20 Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors addresses the gap that exists in research on the topic, gathering multidisciplinary knowledge and tools that help the reader understand the basics of cognitive enhancement. It also provides assistance in designing procedures and pharmacological approaches to further the use of novel cognitive enhancers, a field that offers potential benefit to a variety of populations, including those with neurologic and psychiatric disorders, mild aging-related cognitive impairment, and those who want to improve intellectual performance. The text builds on our knowledge of the molecular/cellular basis of cognitive function, offering the technological developments that may soon enhance cognition. Separate sections cover enhancement drugs, environmental conditions, and genetic factors in terms of both human and animal studies, including both healthy/young and aging/diseased individuals. - Provides a multidisciplinary knowledge, enabling a further understanding of cognitive enhancement - Offers coverage of the pharmacologic, environmental, and genetic factors relevant to the topic - Discusses cognitive enhancement from the perspective of both healthy and diseased or aging populations - Topics are discussed in terms of both human and animal studies |
| alpha brain double blind study: Theory-Driven Approaches to Cognitive Enhancement Lorenza S. Colzato, 2017-09-05 This book provides a comprehensive overview of cognitive enhancement, the use of different substances and actions (e.g., meditation, video game, smart drugs, food supplements, nutrition, brain stimulation, neurofeedback, physical exercise, music, or cognitive training) to enhance human perception, attention, memory, cognitive control, and action in healthy individuals. Chapters contain research on enhancing procedures and activities that will help to further develop enhancement based on individual needs and interests. Chapters also discuss the underlying mechanism of how these means influence and change behaviors and moods. In addition, the book also provides “real-life” examples in which the several means of cognitive enhancement have been successfully applied. It concludes with a call to develop more specific, mechanistic theories to guide cognitive enhancing programs as well as the editor’s own tailored-approach proposal for enhancing cognition for individuals. Featured topics include: The effect of caffeine on cognitive abilities. Aerobic exercise and its short-term and long-term effects on cognition. The effect, if any, of Ritalin and Modafinil on promoting cognitive enhancement. Temperature variations and its influences on behavior. The effect of food supplements across the lifespan. Theory-Driven Approaches to Cognitive Enhancement is a must-have resource for psychologists, physicians, sport and exercise scientists, medical scientists, and teachers. “This book provides a state-of-the-art overview of different aspects of cognitive enhancement. The chapters are very focused, well-structured, in-depth, and rounded up by excellent illustrations. I highly recommend the book to readers interested in the matter”. Dr. Julia Karbach, Goethe University “It is overall a highly original book on a timely topic, with a fresh approach and rich in practical and societal implications. The book is written in a very clear way and it is a pleasure to read.” Dr. Anna M. Borghi, Sapienza University of Rome |
| alpha brain double blind study: The Geomagnetic Field David J. Knecht, 1972 This survey summarizes what is known about the magnetic field of the earth, based on information available through 1971. Observed phenomena are described and interpreted in terms of the most widely accepted physical explanations. An overview of the geomagnetic field and its dynamic relationship with its terrestrial and interplanetary environment is first presented as briefly as possible, followed by more detailed descriptions of geomagnetic measurements and experimental methods, precise current models and past behavior of the main field, regular variations in the field resulting from the motion of the earth, disturbance variations of the field produced by interplanetary environment, and dynamic processes occurring in the outer magnetosphere. Extensive references is a replacement for Chapter 11 of Handbook of Geophysics and Space Environment (Shea L. Valley, ed.), Air Force Cambridge Research Laboratories and McGraw-Hill Book Co., New York, 1965. |
| alpha brain double blind study: Dietary Supplement Use Among U.S. Adults Has Increased Since NHANES III (1988-1994) , 2011 This report provides estimates of dietary supplement use for specific population groups over time. In addition to overall use of dietary supplements, this report focuses on estimates for specific nutrients consumed through dietary supplement use.--Cover. |
| alpha brain double blind study: Nutraceuticals in Health and Disease Prevention Klaus Kramer, Peter-Paul Hoppe, Lester Packer, 2001-05-15 Promoting scientific support for the plethora of health benefits related to nutrition and medicine, Nutraceuticals in Health and Disease Prevention delivers a comprehensive and scientifically sound overview of the latest research findings in disease prevention, therapy, and enhanced body function in the revolutionary field of nutraceutical technolo |
| alpha brain double blind study: Sleep and Cognition Richard R. Bootzin, John F. Kihlstrom, 1990-01-01 Despite impressive advances in understanding sleep as a biological phenomenon and in understanding the nature of mental processes in the normal waking state, our knowledge of mental life during sleep remains extremely impoverished. The common identification of cognition with consciousness leaves the impression that little or no mental activity occurs during sleep. The present volume represents the Proceedings of the Arizona Conference on Sleep and Cognition, held in Tucson January 19-22, 1989. A principal concern of the conference was the implications of recent work on implicit memory and other aspects of information-processing outside of awareness for studies of cognitive processes during sleep, and the role of the sleep laboratory as a vehicle for studying various aspects of information processing outside of awareness, in the absence of the active deployment of attention. To this end, selected investigators in the area of sleep who have an interest in cognitive processes were brought together with their counterparts in the area of cognition who have an interest in sleep. We hope that one outcome of this meeting, and publication of the Proceedings, will be a new agenda for research on sleep that will carry investigators of both camps well into the 21st century. |
| alpha brain double blind study: Brain Protection in Schizophrenia, Mood and Cognitive Disorders Michael S. Ritsner, 2010-06-16 Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms. These mechanisms have implications not only for neurodegenerative disorders, but also for schizophrenia, mood and cognitive disorders. The purpose of this book is to provide an up-to-date overview of basic and clinical studies concerning the neuroprotective approach, mechanisms, and several compounds with neuroprotective properties that may contribute to more efficacious treatment of major mental health disorders. The book is divided into two sections. The first section serves as an introduction and overview of conceptual issues of the neuroprotective approach, and some neurobiological advances. Chapters in this section review definitions, perspectives, and issues that provide a conceptual base for the rest of the book. In addition, this part includes chapters in which the authors present and discuss the findings from basic studies of neurodegenerative mechanisms that are associated with the pathogenesis of major mental health disorders. The second section focuses on findings obtained from clinical trials with neuroprotective compounds, and neuromodulatory techniques. The take-home message is that principles of the neuroprotective approach may be applied to treatment of schizophrenia, mood and cognitive disorders. Contributors to this book are among the most active investigators and clinicians in the field who provide new perspectives not only clarifying ongoing controversies but also propose diverse aspects and new insights to neuroprotection. This book is intended for a broad readership, which includes a broad spectrum of readers including neuroscientists, psychiatrists, neurologists, pharmacologists, clinical psychologists, general practitioners, geriatricians, graduate students, and policy makers in the fields of mental health. |
| alpha brain double blind study: Rhythms of the Brain G. Buzsáki, 2011 Studies of mechanisms in the brain that allow complicated things to happen in a coordinated fashion have produced some of the most spectacular discoveries in neuroscience. This book provides eloquent support for the idea that spontaneous neuron activity, far from being mere noise, is actually the source of our cognitive abilities. It takes a fresh look at the coevolution of structure and function in the mammalian brain, illustrating how self-emerged oscillatory timing is the brain's fundamental organizer of neuronal information. The small-world-like connectivity of the cerebral cortex allows for global computation on multiple spatial and temporal scales. The perpetual interactions among the multiple network oscillators keep cortical systems in a highly sensitive metastable state and provide energy-efficient synchronizing mechanisms via weak links. In a sequence of cycles, György Buzsáki guides the reader from the physics of oscillations through neuronal assembly organization to complex cognitive processing and memory storage. His clear, fluid writing-accessible to any reader with some scientific knowledge-is supplemented by extensive footnotes and references that make it just as gratifying and instructive a read for the specialist. The coherent view of a single author who has been at the forefront of research in this exciting field, this volume is essential reading for anyone interested in our rapidly evolving understanding of the brain. |
| alpha brain double blind study: Nutritional Influences on Bone Health Connie M. Weaver, Robin M. Daly, Heike A. Bischoff-Ferrari, 2016-08-01 The 9th International Symposium is the only regular meeting in the bone field to be exclusively devoted to nutrition, bone and muscle, and it allows the authors of this book to review the new scientific data, discuss new concepts, and update the knowledge on several nutrients. The Symposium provides a unique opportunity to connect health professionals, researchers and industry across many disciplines, including nutrition and dietetics, exercise science, gerontology, nursing, general practice, academia and the food and fitness industry. Most causes for osteoporosis, like genetics, age, menopause, and associated diseases with their treatments, are not modifiable. The investigation of the influence of nutrition on bone health is important as a key modifiable factor of the development of bone and the prevention of osteoporosis. It is the privilege of this symposium to gather every three years with scientists from all over the world working in this field. |
| alpha brain double blind study: Preventing Cognitive Decline and Dementia National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Preventing Dementia and Cognitive Impairment, 2017-10-05 Societies around the world are concerned about dementia and the other forms of cognitive impairment that affect many older adults. We now know that brain changes typically begin years before people show symptoms, which suggests a window of opportunity to prevent or delay the onset of these conditions. Emerging evidence that the prevalence of dementia is declining in high-income countries offers hope that public health interventions will be effective in preventing or delaying cognitive impairments. Until recently, the research and clinical communities have focused primarily on understanding and treating these conditions after they have developed. Thus, the evidence base on how to prevent or delay these conditions has been limited at best, despite the many claims of success made in popular media and advertising. Today, however, a growing body of prevention research is emerging. Preventing Cognitive Decline and Dementia: A Way Forward assesses the current state of knowledge on interventions to prevent cognitive decline and dementia, and informs future research in this area. This report provides recommendations of appropriate content for inclusion in public health messages from the National Institute on Aging. |
| alpha brain double blind study: Cumulated Index Medicus , 1974 |
| alpha brain double blind study: Burket's Oral Medicine Michael Glick, Martin S. Greenberg, Peter B. Lockhart, Stephen J. Challacombe, 2021-10-05 This thoroughly revised Thirteenth Edition of Burket's Oral Medicine reflects the scope of modern Oral Medicine with updated content written by 80 contributing oral medicine and medical experts from across the globe. The text emphasizes the diagnosis and management of diseases of the mouth and maxillofacial region as well as safe dental management for patients with complex medical disorders such as cardiovascular disease, cancer, infectious diseases, bleeding disorders, renal diseases, and many more. In addition to comprehensively expanded chapters on oral mucosal diseases, including those on ulcers, blisters, red, white and pigmented lesions, readers will also find detailed discussions on: orofacial pain, temporomandibular disorders, headache and salivary gland disease; oral and oropharyngeal cancers, including the management of oral complications of cancer therapy; genetics, laboratory medicine and transplantation medicine; pediatric and geriatric oral medicine; psychiatry and psychology; clinical research; and interpreting the biomedical literature The Thirteenth Edition of Burket's Oral Medicine is an authoritative reference valuable to students, residents, oral medicine specialists, teachers, and researchers as well as dental and medical specialists. |
| alpha brain double blind study: Psycho-oncology Jimmie C. Holland, 2015 Originally published by Oxford in 1998, Psycho-Oncology was the first comprehensive text in the field and remains the gold standard today. Edited by a team of leading experts in psycho-oncology, spearheaded by Dr. Jimmie C. Holland, the founder of the field, the text reflects the interdisciplinary nature and global reach of this growing field. Thoroughly updated and developed in collaboration with the American Psychosocial Society and the International Psycho-oncology Society, the third edition is a current, comprehensive reference for psychiatrists, psychologists, oncologists, hospice workers, and social workers seeking to understand and manage the psychological issues involved in the care of persons with cancer and the psychological, social, and behavioral factors that contribute to cancer risk and survival. New to this edition are chapters on gender-based and geriatric issues and expanded coverage of underserved populations, community based programs, and caregiver training and education. |
| alpha brain double blind study: The Scientific Basis of Integrative Health Leonard Wisneski, 2017-05-25 Since the first suffering supplicant offered a prayer to his god or the first mother cradled an ailing child in her caring arms, we have witnessed how human health and healing go beyond any inventory of parts and infusion of chemicals. We humans are a complex melding of thought, emotion, spirit and energy and each of those components is as critical to our well-being as our physiological status. Even if we are just beginning to quantify and document these seemingly intangible aspect, to ignore them in the practice of medicine is neglect and an invitation to do harm. The Scientific Basis of Integrative Health has been extensively updated and expanded to provide a comprehensive guide to integrative medicine. Taking a balanced and objective approach, this leading text bridges the gap between Western science and Eastern philosophy. It provides doctors and other health practitioners with information on complementary and alternative approaches to health, that is authoritative, evidence based, and epidemiologically substantiated. Written for doctors and healthcare professionals by pioneering practitioners and updated with the newest research across and increasing range of possibilities, this third edition includes nine new chapters covering topics such as: Electrophotonic imaging; Neuroacupuncture; Naturopathic medicine; Integrative nutrition. |
| alpha brain double blind study: Biohacker's Handbook Olli Sovijärvi, M.D., Teemu Arina, Jaakko Halmetoja, Biohacking is all about optimizing human performance, health and well-being by utilizing science, technology and a deep understanding of human physiology and nutrition. Biohacker’s Handbook is the most anticipated health & wellness book of the decade. The authors – Olli Sovijärvi, M.D., technology expert Teemu Arina and nutrition expert Jaakko Halmetoja – upgrade the fundamentals of a balanced life: sleep, nutrition, exercise, work and the mind. What is the 20 % that will lead to 80 % of the results when it comes to optimal well-being? Biohacker’s Handbook takes the latest research into holistic health and turns it into practical and applicable information in a visual and readable format. With more than 1500 references and hundreds of images, Biohacker’s Handbook is “the missing manual of the human body” and an essential addition to the library, work desk, kitchen, gym, suitcase and bedroom of anyone with a genuine interest in optimal human performance, health and wellbeing. Pages: (572 in printed version) References: 1634 Edition: 1st Authors: Olli Sovijärvi, Teemu Arina, Jaakko Halmetoja Visual design, layout and illustrations: Lotta Viitaniemi |
| alpha brain double blind study: Integrative Addiction and Recovery Shahla Modir, George Munoz, 2018-11-13 Integrative Addiction and Recovery offers an authentic model of comprehensive integrative modalities germane and specific to the field of addiction and recovery treatment. Although many treatment services for addiction include holistic, alternative, or integrative in their descriptions, they contain no substantive programs or services consistent with the mind, body, spirit paradigm contained within the integrative approach to health and healing. Consequently, many patients do not have the opportunity to benefit from the true spirit of an integrative approach within the discipline of addition and recovery medicine. This book sets the standard for a bona fide integrative approach for others to follow, providing information that is immediately useful in clinical practice and rigorously evidence-based. Authored by world-class experts in the field of addiction medicine, Integrative Addiction and Recovery presents both scientific and holistic data regarding a wide variety of holistic and conventional approaches to the treatment of substance abuse and behavioral addictions. Its chapters cover both conventional and holistic treatment and provide background for each of the major classes of drugs of abuse, including opiates, alcohol, tobacco, stimulants, sedative-hypnotics, hallucinogens and marijuana. It also includes chapters on the topics of food addiction and behavioral addictions such as gambling and shopping. The authors explore the major holistic modalities, providing background and theory in areas like acupuncture, Traditional Chinese Medicine, Homeopathy, Aromatherapy, and Ayurvedic Medicine, while at the same time providing spiritual approach chapters on Shamanism and Ibogaine, as well as more conventional issues with a holistic view including Co-Occurring Disorders and Psychosocial Treatment, and Group Support. The very complex issue of chronic pain and addiction is also addressed, along with relapse prevention strategies. |
| alpha brain double blind study: Learning and Communication Disorders American Psychological Association, 1982 4035 entries to journal articles and monographs published between 1971-1980. Intended for parents, educators, researchers, and practitioners. Sources were publications from all countries in fields of psychology, education, medicine, and social sciences. Classified arrangement. Each entry gives author, title, abstract, author's institution, and bibliographical information. Subject, author indexes. |
| alpha brain double blind study: Heaven's Breath Lyall Watson, 2019-08-13 A “comprehensive and fascinating study” of how wind has shaped the world as we know it, affecting all aspects of human and natural life—from geography to political history, plant life to psychology, and biology to philosophy (The Observer) Wind is everywhere and nowhere. Wind is the circulatory system of the earth, and its nervous system, too. Energy and information flow through it. It brings warmth and water, enriches and strips away the soil, aerates the globe. Wind shapes the lives of animals, humans among them. Trade follows the path of the wind, as empire also does. Wind made the difference in wars between the Greeks and Persians, the Mongols and the Japanese. Wind helped to destroy the Spanish Armada. And wind is no less determining of our inner lives: the föhn, mistral, sirocco, Santa Ana, and other “ill winds” of the world are correlated with disease, suicide, and even murder. Heaven’s Breath is an encyclopedic and enchanting book that opens dazzling new perspectives on history, nature, and humanity. |
| alpha brain double blind study: Co-planar Stereotaxic Atlas of the Human Brain Jean Talairach, Pierre Tournoux, 1988-01-01 In this superb atlas, the distinguished authors offer the proportional grid system of brain imaging. This unique process makes it possible to localize neuroanatomic structures not visible with traditional radiologic methods. Unlike the classic method of spatial reading, which is valid only with the particular brain under consideration, the proportional grid creates a frame of reference applicable to all brains being examined. This is especially beneficial for clinical studies, electroencephalographic investigations, and statistical computations. Special features of the book include: A full, three-dimensional atlas of the human brain A series of anatomic sections done for the frontal, horizontal, and sagittal planes Practical examples for use in neuroradiologic examinations and basal lines forming a frame of reference that defines orientation and spatial position of structures within the cerebral mass. This stereotaxic process is designed to maximize accuracy, reliability, and safety. The information in this valuable atlas is essential for all radiologists, neurologists, neurosurgeons, and all specialists involved in the neurosciences. Use this practical mapping tool for understanding the pathologic processes of the human brain. |
| alpha brain double blind study: Science of the Placebo Harry Guess, Linda Engel, Arthur Kleinman, John Kusek, 2002-03-15 Based on a meeting in November 2000, this book brings together researchers from a wide range of disciplines to examine the biological, behavioral, social, cultural and ethical aspects related to the placebo effect. Perspectives on the necessity for including a placebo in randomized clinical trials will also be examined. This is the first attempt to examine the evidence-base of the placebo effect and will provide important information for clinicans. |
| alpha brain double blind study: Psychiatry Allan Tasman, Jerald Kay, Jeffrey A. Lieberman, Michael B. First, Michelle Riba, 2015-01-29 Now in a new Fourth Edition, Psychiatry remains the leading reference on all aspects of the current practice and latest developments in psychiatry. From an international team of recognised expert editors and contributors, Psychiatry provides a truly comprehensive overview of the entire field of psychiatry in 132 chapters across two volumes. It includes two new sections, on psychosomatic medicine and collaborative care, and on emergency psychiatry, and compares Diagnostic and Statistical Manual (DSM-5) and International Classification of Diseases (ICD10) classifications for every psychiatric disorder. Psychiatry, Fourth Edition is an essential reference for psychiatrists in clinical practice and clinical research, residents in training, and for all those involved in the treatment psychiatric disorders. Includes a a companion website at www.tasmanpsychiatry.com featuring PDFs of each chapter and downloadable images |
| alpha brain double blind study: Psychopharmacology Bulletin , 1990 |
| alpha brain double blind study: Cognitive Impairment in Schizophrenia Philip D. Harvey, 2013-01-24 Provides state-of-the-art information about cognition in schizophrenia with a wide ranging focus on measuring and treating cognitive deficits. |
| alpha brain double blind study: Health Psychology Richard O. Straub, 2007 In its first edition, Richard Straub's text was acclaimed for its solid scientific approach, emphasis on critical thinking, real-world applications, exquisite anatomical art, and complete media/supplements package. The thoroughly updated new edition builds on those strengths to provide an even more effective introduction to the psychology behind why we get sick, how we stay well, how we react to illness, and how we relate to the health care system and health care providers. |
| alpha brain double blind study: Braddom's Physical Medicine and Rehabilitation David X. Cifu, MD, 2015-08-20 The most-trusted resource for physiatry knowledge and techniques, Braddom's Physical Medicine and Rehabilitation remains an essential guide for the entire rehabilitation team. With proven science and comprehensive guidance, this medical reference book addresses a range of topics to offer every patient maximum pain relief and optimal return to function. In-depth coverage of the indications for and limitations of axial and peripheral joints through therapies enables mastery of these techniques. Optimize the use of ultrasound in diagnosis and treatment. A chapter covering PM&R in the international community serves to broaden your perspective in the field. Detailed illustrations allow you to gain a clear visual understanding of important concepts. New lead editor - Dr. David Cifu - was selected by Dr. Randall Braddom to retain a consistent and readable format. Additional new authors and editors provide a fresh perspective to this edition. Features comprehensive coverage of the treatment of concussions and military amputees. Includes brand-new information on rehabilitating wounded military personnel, the latest injection techniques, speech/swallowing disorders, head injury rehabilitation, and the rehabilitation of chronic diseases. New chapters on pelvic floor disorders and sensory impairments keep you at the forefront of the field. Reader-friendly design features an updated table of contents and improved chapter approach for an enhanced user experience. Expert Consult eBook version included with purchase. This enhanced eBook experience gives access to the text, figures, over 2,500 references, 51 videos, and 750 self-assessment questions on a variety of devices. |
| alpha brain double blind study: Anti-Aging Therapeutics Volume XVII A4M American Academy of Anti-Aging Medicine, 2015-11-12 Proceedings of the Twenty-Second World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies, sponsored by the American Academy of Anti-Aging Medicine (A4M). |
| alpha brain double blind study: Federal Register , 1979-04-10 |
| alpha brain double blind study: Bipolar Psychopharmacotherapy Hagop S. Akiskal, Mauricio Tohen, 2011-06-24 If a colleague were to ask me, What would you recommend I read if I want to become a real expert on bipolarity? I would respond Bipolar Psychopharmacotherapy: Caring for the Patient. Journal of Bipolar Disorders And the second edition is even better! Bipolar Psychopharmacotherapy covers both pharmacotherapy and the supportive role of psychotherapy, psychoeducation and social approaches to provide a broad integrative philosophy of care for bipolar patients. Extensive coverage is given to special management issues such as the pharmacological care of women with bipolar disorder, children and the elderly, as well as bipolar depression and suicide prevention. The mood swings that characterize bipolar disorder can now be better stabilized in most patients than in the past, but the illness must be carefully managed throughout a person's life. Pharmacotherapy is central to the acute treatment and long-term management and as there are several classes of drugs which are often prescribed concurrently, treatment issues are complex. This essential reference work features critical reviews of the existing literature, plus information on new treatments that have been reported at peer reviewed scientific meetings, often written by the pioneering experts on a particular treatment. The second-generation antipsychotics are now covered in separate chapters to provide in-depth coverage of these agents. There are also new chapters on the pharmacological treatments of mixed states and rapid cycling and novel therapeutic vistas. |
| alpha brain double blind study: Brain Edema XII T. Kuroiwa, A. Baethmann, Z. Czernicki, J.T. Hoff, U. Ito, Y. Katayama, A. Marmarou, D. Mendelow, H.-J. Reulen, 2012-12-06 Brain edema is a simple phenomenon – an abnormal increase of brain tissue volume by the increase of brain tissue water content. However the etiology is not simple and relating to a wide variety of neurological disorders including ischemia, trauma, tumor, hemorrhage and hydrocephalus. It is still a major cause of death in the neurological/neurosurgical ward. This volume is an up-to-date report on progress in brain edema research, diagnosis and treatment, including papers presented at the 12th International Symposium on Brain Edema and Brain Tissue Injury in 2002. Major topics include molecular biology and blood-brain barrier disorders, ischemic and traumatic brain edema, imaging and diagnosis of brain edema, treatment and radiation effect. Various papers in the rapidly growing fields of neuroimaging and molecular medicine are also included. |
| alpha brain double blind study: Psychology Charles G. Morris, Joyce Bishop, Veronica Bishop, 1996 |
| alpha brain double blind study: Brain Disorders in Critical Illness Robert D. Stevens, Tarek Sharshar, E. Wesley Ely, 2013-09-19 Brain dysfunction is a major clinical problem in intensive care, with potentially debilitating long-term consequences for post-ICU patients of any age. The resulting extended length of stay in the ICU and post-discharge cognitive dysfunction are now recognized as major healthcare burdens. This comprehensive clinical text provides intensivists and neurologists with a practical review of the pathophysiology of brain dysfunction and a thorough account of the diagnostic and therapeutic options available. Initial sections review the epidemiology, outcomes, relevant behavioral neurology and biological mechanisms of brain dysfunction. Subsequent sections evaluate the available diagnostic options and preventative and therapeutic interventions, with a final section on clinical encephalopathy syndromes encountered in the ICU. Each chapter is rich in illustrations, with an executive summary and a helpful glossary of terms. Brain Disorders in Critical Illness is a seminal reference for all physicians and neuroscientists interested in the care and outcome of severely ill patients. |
A randomized, double-blind, placebo controlled, parallel …
randomized, double-blind, placebo controlled design. Methods A total of 63-treatment naïve individuals participated in this randomized, double-blind, placebo controlled trial. All …
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF …
Alpha BRAIN® on the manufacturers purported target population of healthy adults utilizing a randomized, double-blind, placebo controlled trial using standardized tests of learning, …
Double-blind, randomized pilot clinical trial targeting alpha ...
Here we evaluated the feasibility and efficacy of transcranial alternating current stimulation (tACS) at 10 Hz, which we hypothesized would improve clinical symptoms by renormalizing alpha...
The Efficacy of A Nootropic Supplement on Information …
Objectives: This study aimed to investigate the efficacy of a nootropic, Mind Lab Pro, on the performance of simple reaction time (SRT), choice reaction time (CRT) and anticipation, in a …
S UMMA RY O F CLI NI CA L S T UDI E S
A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly. In 2004, this study found that Ginkgo "might be helpful in treating the …
Alpha Brain Double Blind Study (Download Only) - x-plane.com
using appropriate signal analysis techniques This has resulted in the recognition of alpha activities in place of the classical unitary alpha rhythm Second the attempts to use a hemisphere …
Specific neuromodulation induced by alpha-based - bioRxiv
Dec 2, 2020 · modulation of individual alpha EEG activity induced by NFT in a double-blind, randomized, sham-controlled study. Forty-eight healthy participants were assigned to either …
Double-blind, randomized pilot clinical trial targeting alpha ...
To test this hypothesis, we conducted a pilot double-blind study to evaluate the feasibility, safety, and ef ficacy of tACS as a treatment for the symptoms of depression. Patients diagnosed...
A Randomized Double-Blind Placebo-Controlled Trial of a …
This was a randomized, placebo-controlled, double-blind study to assess the effects of MBB (provided by Besten Corporation, Irwindale, CA, USA) on multiple measures of cognition in …
Alpha transcranial alternating current stimulation reduces …
In a recent double-blind clinical trial from our group49,51, 10-Hz tACS enhanced alpha power in schizophrenia patients with auditory hallucinations at the end of the course of a 5-day...
Alpha Brain Double Blind Study - x-plane.com
A well-designed alpha brain double blind study is crucial for determining if Alpha Brain's purported benefits are real or merely a result of expectation. (Note: At present, there is no widely …
A Randomized, Controlled, Double-Blind Pilot Study of the …
Objective: To investigate the effects of microcurrent cranial electrical stimulation (CES) therapy on activity in pain process-ing brain regions. Design: A randomized, controlled, three-group, …
Selective neuromodulation induced by alpha-based …
We aimed at investigating the modulation of individual alpha EEG activity induced by NFT in a double-blind, randomized, sham-controlled study. Methods: Forty-eight healthy participants …
Double-Blind, Sham-Controlled, Pilot Study of Trigeminal …
The present study investigated the potential efficacy of TNS for ADHD treatment in a 4-week double-blinded sham-controlled trial followed by 1 blinded week without treatment to assess …
Clinical effectiveness of active Alpha-Stim AID versus sham …
Methods The Alpha-Stim-D trial was a multicentre, parallel group, double-blind, randomised controlled trial, recruiting participants from 25 primary care centres in two regions in England, …
Double-Blind Single-Session Neurofeedback Training in …
Abstract—This paper reports on a single-session neurofeed-back (NF) training procedure on the user-specific upper alpha band for cognitive enhancement in healthy users. A double-blind …
Limitations of the Double-Blind Pharmaceutical Study - PNI
double-blind studies are the standards by which drugs are approved. Indeed, within the United States, the FDA [Federal Drug Administration] generally requires two double-blind studies …
The Effect of Beta and Alpha Neurofeedback on Memory: A …
Objective: The present study aimed at examining the effect of 2 neurofeedback protocols “beta up-training” and “low alpha/ high alpha ratio suppression” on memory performance. Methods: …
Alpha Brain Double Blind Study (Download Only) - x-plane.com
Alpha Brain Double Blind Study : Delia Owens "Where the Crawdads Sing" This captivating coming-of-age story follows Kya Clark, a young woman who grows up alone in the marshes of …
A randomized, double-blind, placebo controlled, paralle…
randomized, double-blind, placebo controlled design. Methods A total of 63-treatment naïve individuals participated in this randomized, …
UNITED STATES DISTRICT COURT SOUTHERN DISTRIC…
Alpha BRAIN® on the manufacturers purported target population of healthy adults utilizing a randomized, double-blind, placebo controlled trial using …
Double-blind, randomized pilot clinical trial targeting …
Here we evaluated the feasibility and efficacy of transcranial alternating current stimulation (tACS) at 10 Hz, which we hypothesized would …
The Efficacy of A Nootropic Supplement on Informatio…
Objectives: This study aimed to investigate the efficacy of a nootropic, Mind Lab Pro, on the performance of simple reaction time (SRT), choice …
S UMMA RY O F CLI NI CA L S T UDI E S
A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly. In 2004, this study found …
